Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ExCell: Ex-vivo Cultivated Limbal Stem Cell Transplantation
NCT02948023Phase 1Unknown
- Sponsor
- L V Prasad Eye Institute
- Start
- Aug 2016
- Primary completion
- Feb 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in corneal injury, Corneal burn, Corneal scar and 1 more (2 arms), sponsored by L V Prasad Eye Institute. Primary endpoint: Ocular or systemic adverse effects at 3 months. Status: unknown.
02
Conditions
corneal injuryCorneal burnCorneal scarcorneal opacity
Beyond the preview
Go deeper on NCT02948023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02948023.